Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 22 October 2014 | By Stewart Eisenhart,
Content provided by Emergo Group, a medical device regulatory affairs and quality assurance consulting firm with offices worldwide.
The Australian government under Prime Minister Tony Abbott has proposed allowing domestic medical device manufacturers to register their “routine” products in the country using CE Marking certificates from European Notified Bodies.
The proposal, part of a new government position paper pushing innovation and competitiveness issues, would in essence remove Therapeutic Goods Administration (TGA) certification requirements for Australian medical devices that have already obtained CE Mark certification for sale in Europe. (See page 28 of the position paper.)
Currently, the TGA allows importation into Australia of devices from foreign manufacturers with CE Marking; domestic manufacturers that have already obtained CE Marking for their devices, however, must still register with the TGA for market authorization in Australia. As a result, “our manufacturers face more unpredictable and lengthier timeframes for regulation domestically that their overseas competitors,” according to the government’s proposal.
“What this could mean is that in Australia, importers and local manufacturers would be on the same footing,” says Dr. Mike Skalsky, Managing Director at Emergo Australia. “But remember that the TGA recently adopted a more scrutinizing approach to CE Marking from some Notified Bodies due to safety and performance issues. The duplication for local manufacturers has been one of the subjects frequently raised by the local industry bodies, so it will be interesting to see whether the government will finally act on this issue.”
(Original Post)
Tags: CE Marking, Tony Abbott
Regulatory Focus newsletters
All the biggest regulatory news and happenings.